Cargando…

Identification and optimisation of next generation inhibitors of IDO1 and TDO

Detalles Bibliográficos
Autores principales:	Wise, Alan, Cowley, Phillip, McGuinness, Barry, Trewick, Sarah E, Brown, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652572/ http://dx.doi.org/10.1186/2051-1426-3-S2-P422

Ejemplares similares

On the Non-Redundant Roles of TDO2 and IDO1
por: Puccetti, Paolo
Publicado: (2014)

Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
por: Platten, Michael, et al.
Publicado: (2015)

Role of IDO and TDO in Cancers and Related Diseases and the Therapeutic Implications
por: Ye, Zixiang, et al.
Publicado: (2019)

Preclinical assessment of a novel small molecule inhibitor of tryptophan 2,3-dioxygenase 2 (TDO2)
por: Crosignani, Stefano, et al.
Publicado: (2014)

Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO
por: Kim, Minah, et al.
Publicado: (2021)

Induction of TDO2 and IDO2 in Liver by High-Fat Feeding in Mice: Discrepancies with Human Obesity
por: Poulain-Godefroy, Odile, et al.
Publicado: (2013)

Preclinical PK investigation of a novel IDO1/TDO dual inhibitor—SHR9146 in mouse plasma and tissues by LC-MS/MS
por: Xiao, Mei, et al.
Publicado: (2023)

The role and function of noise and neural heterogeneity in the integrated population response of the vestibulo-ocular reflex
por: McGuinness, James, et al.
Publicado: (2011)

Functional role and implications of population heterogeneity on vestibular ocular reflex response fidelity
por: McGuinness, James, et al.
Publicado: (2013)

Treatment with the IDO inhibitor INCB024360 increased lysis of human tumor cell targets by peptide-specific CTL
por: Jochems, Caroline, et al.
Publicado: (2015)

Preclinical assessment of a novel small molecule inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1)
por: Driessens, Gregory, et al.
Publicado: (2014)

Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway
por: Du, Lisha, et al.
Publicado: (2020)

IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era
por: Chen, Xiangli, et al.
Publicado: (2020)

Indoximod opposes the immunosuppressive effects mediated by IDO and TDO via modulation of AhR function and activation of mTORC1
por: Brincks, Erik L., et al.
Publicado: (2020)

Correction: Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway
por: Du, Lisha, et al.
Publicado: (2021)

Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening
por: Sari, Suat, et al.
Publicado: (2019)

Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice
por: Zhang, Rongjie, et al.
Publicado: (2022)

Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer
por: Wu, Chunjing, et al.
Publicado: (2023)

Next-generation sequencing at Merck-Boston
por: Stevens, Richard
Publicado: (2012)

Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2
por: Tijono, Sofian M, et al.
Publicado: (2022)

A next-generation chemistry database cartridge
por: Ihlenfeldt, Wolf D
Publicado: (2013)

Combined radiotherapy and immunotherapy using CPG oligodeoxynucleotides and indolamine 2,3 dioxygenase (IDO) blockade
por: Monjazeb, Arta M, et al.
Publicado: (2013)

Identification of genes located at breakpoints of uncharacterized chromosomal translocations by the use of chromosomal microdissection and next generation DNA sequencing
por: Campregher, Paulo V, et al.
Publicado: (2013)

Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine
por: Berrong, Zuzana, et al.
Publicado: (2014)

CLIA-certified next-generation sequencing analysis in the cloud
por: Zhang, Ying, et al.
Publicado: (2012)

Deploying next-generation sequencing in a hospital setting
por: Jorgensen, Lars GT, et al.
Publicado: (2012)

Respiratory syncytial virus replication induces Indoleamine 2,3-dioxygenase (IDO) activation in human dendritic cells
por: Ajamian, Farnam, et al.
Publicado: (2010)

SNP discovery in apple cultivars using next generation sequencing
por: Alencar, Sérgio, et al.
Publicado: (2011)

Next generation sequence analysis of the transcriptional response to neonatal hyperoxia
por: Bhattacharya, Soumyaroop, et al.
Publicado: (2014)

Next-generation dendritic cells for immunotherapy of acute myeloid leukemia
por: Schnorfeil, Frauke, et al.
Publicado: (2014)

microRNAs and next generation sequencing for the prognosis of the metastatic melanoma
por: Pinto, Rosamaria, et al.
Publicado: (2015)

TDO Promotes Hepatocellular Carcinoma Progression
por: Li, Shanbao, et al.
Publicado: (2020)

Preliminary validation of nCounter PanCancer immune profiling of FFPE slides and pbmc in CITN-05, a CITN study of the immunological effects of an IDO1 inhibitor in patients with ovarian carcinoma
por: Dennis, Lucas, et al.
Publicado: (2015)

Optimising trial monitoring on the AZURE trial
por: Matthews, Geraldine A, et al.
Publicado: (2011)

Next-generation gene catalogues and genomics tools focused on forestry research
por: Rigault, Philippe
Publicado: (2011)

Genotype-Phenotype correlations in Joubert Syndrome in the Era of Next Generation Sequencing
por: Bachmann-Gagescu, R, et al.
Publicado: (2015)

Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models
por: Spahn, Jessica, et al.
Publicado: (2015)

jsMolEditor: an open source molecule editor for the next generation web
por: Duan, L
Publicado: (2010)

Characterizing the small RNA transcriptome associated with COPD and ILD using next-generation sequencing
por: Campbell, Joshua D, et al.
Publicado: (2012)

Targeted next-generation sequencing of colorectal cancer identified metastatic specific genetic alterations
por: Brannon, A Rose, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_nkdhg03eajij7usfur4fg77gd3